Regencell Bioscience Holdings Limited Ordinary Shares
RGC
Closed
$6.19
Closed
-(-)
At close
Get professional financial guidance
Schedule your free first call with a financial advisor on CUSP Wealth
*T&Cs apply
About
Regencell Bioscience Holdings Ltd. is a early-stage bioscience company that focuses on research, development and commercialization of Traditional Chinese Medicine for the treatment of neurocognitive disorders and degeneration, specifically Attention Deficit Hyperactivity Disorder and Autism Spectrum Disorder. The company employs 10 full-time employees The company went IPO on 2021-07-16. The firm launches three liquid based standardized TCM formulae candidates for mild, moderate and severe ADHD and ASD patients.
Key stats
Open
$6.07
Volume
600.65K
Market cap
$2.89B
Prev. close
$6.07
Impl / hst vl
-
Open interest
$0.00
$5.75
Day’s Range
$6.21
$5.17
52W Range
$69.00
Valuation
22
Valuation score
Overvalued
P/E
-
P/S
-
P/B
594.33
Current ratio
-
Debt / Equity
-
ROE
-61.90%
Gross margin
-
Income growth
-6.64%
FCF growth
-
Analysts estimates
Earnings
Q2 ‘25 revenue
$0.00
Q2 ‘25 net income
-$1.73M
Revenue
Net income
Discover more Shariah-compliant stocks
Explore the Healthcare sector
Get professional financial guidance
Schedule your free first call with a financial advisor on CUSP Wealth
*T&Cs apply